EP0733057A4 - Origin of replication complex genes, proteins and methods - Google Patents

Origin of replication complex genes, proteins and methods

Info

Publication number
EP0733057A4
EP0733057A4 EP95904929A EP95904929A EP0733057A4 EP 0733057 A4 EP0733057 A4 EP 0733057A4 EP 95904929 A EP95904929 A EP 95904929A EP 95904929 A EP95904929 A EP 95904929A EP 0733057 A4 EP0733057 A4 EP 0733057A4
Authority
EP
European Patent Office
Prior art keywords
origin
proteins
methods
replication complex
complex genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95904929A
Other languages
German (de)
French (fr)
Other versions
EP0733057A1 (en
Inventor
Bruce W Stillman
Stephen P Bell
Ryuji Kobayashi
Jasper Rine
Margit Foss
Francis J Mcnally
Patricia Laurenson
Herskowitz
Joachim J Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cold Spring Harbor Laboratory
University of California
Original Assignee
Cold Spring Harbor Laboratory
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cold Spring Harbor Laboratory, University of California filed Critical Cold Spring Harbor Laboratory
Publication of EP0733057A1 publication Critical patent/EP0733057A1/en
Publication of EP0733057A4 publication Critical patent/EP0733057A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
EP95904929A 1993-12-16 1994-12-16 Origin of replication complex genes, proteins and methods Withdrawn EP0733057A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16847993A 1993-12-16 1993-12-16
US168479 1993-12-16
PCT/US1994/014563 WO1995016694A1 (en) 1993-12-16 1994-12-16 Origin of replication complex genes, proteins and methods

Publications (2)

Publication Number Publication Date
EP0733057A1 EP0733057A1 (en) 1996-09-25
EP0733057A4 true EP0733057A4 (en) 1998-08-19

Family

ID=22611645

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95904929A Withdrawn EP0733057A4 (en) 1993-12-16 1994-12-16 Origin of replication complex genes, proteins and methods

Country Status (5)

Country Link
EP (1) EP0733057A4 (en)
JP (1) JPH09506768A (en)
AU (1) AU700405B2 (en)
CA (1) CA2178965A1 (en)
WO (1) WO1995016694A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6361954B1 (en) 1996-05-02 2002-03-26 Cold Spring Harbor Laboratory Methods of immunoassay for human CDC6
US5851821A (en) * 1996-05-02 1998-12-22 Cold Spring Harbor Laboratory DNA Replication-regulating genes
US6074819A (en) * 1996-05-02 2000-06-13 Cold Spring Harbor Laboratory DNA replication-regulating genes
US5955275A (en) 1997-02-14 1999-09-21 Arcaris, Inc. Methods for identifying nucleic acid sequences encoding agents that affect cellular phenotypes
US6025485A (en) 1997-02-14 2000-02-15 Arcaris, Inc. Methods and compositions for peptide libraries displayed on light-emitting scaffolds
US6623922B1 (en) 1997-02-14 2003-09-23 Deltagen Proteomics Methods for identifying, characterizing, and evolving cell-type specific CIS regulatory elements
US6281347B1 (en) 1997-09-10 2001-08-28 O'donnell Michael Human origin of replication complex genes and uses thereof
EP0966528A1 (en) 1997-11-07 1999-12-29 Iconix Pharmaceuticals, Inc. Surrogate genetics target characterization method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1536392A (en) * 1991-01-18 1992-08-27 Oncogene Science, Inc. Methods of transcriptionally modulating expression of oncogenes and tumor suppressor genes

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHIEN C -T ET AL: "THE TWO-HYBRID SYSTEM: A METHOD TO IDENTIFY AND CLONE GENES FOR PROTEINS THAT INTERACT WITH A PROTEIN OF INTEREST", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 88, 1 November 1991 (1991-11-01), pages 9578 - 9582, XP000647704 *
LI J.J. & HERSKOWITZ I.: "Isolation of ORC6, a component of the yeast Origin Recognition Complex by a one-hybrid system.", SCIENCE, vol. 262, 17 December 1993 (1993-12-17), pages 1870 - 1874, XP002067718 *
See also references of WO9516694A1 *
WANG M.M. & REED R.R.: "Molecular cloning of the olfactory neuronal transcription factor Olf-1 by genetic selection in yeast", NATURE, vol. 364, 8 July 1993 (1993-07-08), pages 121 - 126, XP002067717 *

Also Published As

Publication number Publication date
AU1373495A (en) 1995-07-03
EP0733057A1 (en) 1996-09-25
WO1995016694A1 (en) 1995-06-22
JPH09506768A (en) 1997-07-08
CA2178965A1 (en) 1995-06-22
AU700405B2 (en) 1999-01-07

Similar Documents

Publication Publication Date Title
AU1108695A (en) Aza-4-iminoquinolines, methods of preparing them and their use
HUP9900422A3 (en) Novel protein and methods for the production of the same
EP0731806A4 (en) SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF
ZA939608B (en) Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof.
EP0681585A4 (en) Tata-binding protein associated factors, nucleic acids encoding tafs, and methods of use.
EP0300031A4 (en) Immunosuppressive peptides and methods of use.
NZ237198A (en) Zymogen form of protein c, dna, vector and use as a pharmaceutical
EP0635029A4 (en) Cartilage matrix protein and methods for use.
GB9516059D0 (en) Novel genes and proteins
IL118375A0 (en) Rhesus OB protein and DNA
AU7938294A (en) Method for controlled modification of enzymes, enzymes modified in this way and the use of such enzymes
AU4013495A (en) Chemokine-like proteins and methods of use
AU8717791A (en) Replication initiator protein complex and methods of use thereof
AU5847194A (en) Novel entomopoxvirus genes, proteins and methods of use thereof
AU6905894A (en) Trichohyalin and transglutaminase-3 and methods of using same
EP0733057A4 (en) Origin of replication complex genes, proteins and methods
AU3241895A (en) Apoptosis related protein bcl-y, and methods of use thereof
IL91335A0 (en) Dna sequence and hepadnavirus
GB2314271B (en) Therapeutic methods and preparations using rubidium ions
AU5369396A (en) Rest protein and dna
HUP9801330A3 (en) Novel pka-binding proteins and uses thereof
EP0572139A3 (en) Enzymatic protein process and product.
AU2770695A (en) Isolated p27 protein and methods for its production and use
AU5545896A (en) H. Influenzae HxuB and HxuC genes, proteins and methods of use
AU7352396A (en) Use of protein S-100b in medicines and medicines containing the protein S-100-b

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960618

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HERSKOWITZ, IRA UNIVERSITY OF CALIFORNIA

Inventor name: LAURENSON, PATRICIA

Inventor name: MCNALLY, FRANCIS, J.

Inventor name: FOSS, MARGIT DUKE UNIVERSITY MEDICAL CENTER

Inventor name: RINE, JASPER

Inventor name: KOBAYASHI, RYUJI

Inventor name: BELL, STEPHEN, P.

Inventor name: STILLMAN, BRUCE, W. , COLD SPRING HARBOR LAB.

RHK1 Main classification (correction)

Ipc: C12N 15/31

A4 Supplementary search report drawn up and despatched

Effective date: 19980701

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20000701